.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Baxter
AstraZeneca
Federal Trade Commission
Chubb
Mallinckrodt
Merck
Covington
Johnson and Johnson
US Department of Justice

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019635

« Back to Dashboard
NDA 019635 describes SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and B Braun and is included in two NDAs. It is available from two suppliers. Additional details are available on the SODIUM CHLORIDE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 5% IN PLASTIC CONTAINER is sodium chloride. There are one thousand three hundred and ninety-two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

Summary for NDA: 019635

Tradename:
5
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Pharmacology for NDA: 019635

Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption

Suppliers and Packaging for NDA: 019635

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
sodium chloride
 INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-7800 0264-7800-00 12 CONTAINER in 1 CASE (0264-7800-00) > 1000 mL in 1 CONTAINER
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
sodium chloride
 INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-7800 0264-7800-10 24 CONTAINER in 1 CASE (0264-7800-10) > 500 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength450MG/100ML
Approval Date:Mar 9, 1988TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength900MG/100ML
Approval Date:Mar 9, 1988TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength3GM/100ML
Approval Date:Mar 9, 1988TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Colorcon
AstraZeneca
Fuji
Covington
McKesson
Mallinckrodt
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot